Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model

Sarah L. Rowland, Jeffrey M. Riggs, Susan Gilfillan, Mattia Bugatti, William Vermi, Roland Kolbeck, Emil R. Unanue, Miguel A. Sanjuan, Marco Colonna

Research output: Contribution to journalArticlepeer-review

172 Scopus citations

Abstract

Plasmacytoid dendritic cells (pDCs) have long been implicated in the pathogenesis of lupus. However, this conclusion has been largely based on a correlative link between the copiousproduction of IFN-α/β by pDCs and the IFN-α/β "signature" often seen in human lupus patients. The specific contribution of pDCs to disease in vivo has not been investigated in detail. For this reason, we generated a strain of BXSB lupus-prone mice in which pDCs can be selectively depleted in vivo. Early, transient ablation of pDCs before disease initiation resulted in reduced splenomegaly and lymphadenopathy, impaired expansion and activation of T and B cells, reduced antibodies against nuclear autoantigens and improved kidney pathology. Amelioration of pathology coincided with decreased transcription of IFN-α/β- induced genes in tissues. PDC depletion had an immediate impact on the activation of immune cells, and importantly, the beneficial effects on pathology were sustained eventhough pDCs later recovered, indicating an early pDC contribution to disease. Together, our findings demonstrate a critical function for pDCs during the IFN-α/β-dependent initiation of autoimmune lupus and point to pDCs as an attractive therapeutic target for the treatment of SLE.

Original languageEnglish
Pages (from-to)1977-1991
Number of pages15
JournalJournal of Experimental Medicine
Volume211
Issue number10
DOIs
StatePublished - 2014

Fingerprint

Dive into the research topics of 'Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model'. Together they form a unique fingerprint.

Cite this